This marks the FIRST antigen rapid test to be approved by Taiwan FDA for the detection of SARS-CoV-2 (COVID-19 virus). Vstrip® will continue to apply for approval from other international regulatory agencies including U.S. FDA (EUA), EU CE certification, and Japan PMDA.
Monthly Archives: August 2020
ESR1 mutations have been reported that will contribute to the resistance of the aromatase inhibitor (AI) in HR+ breast cancer patients in several past studies. However, the role of ESR1 mutation remains unknown when the AI is combined with the CDK4/6 inhibitors. In phase 3 PADA-1 study, 33 of the 1017 enrolled patients (3.2%) harbored an ESR1 mutation before receiving the 1st-line AI plus palbociclib.
Brain tumors are rare but difficult to manage. Glioma is the most common type of tumor in the brain that begins in glial cells. IDH1/2 genes are important genes in both glioma classification and targeted therapy treatment. Adult diffuse gliomas of grade II and III are classified as low-grade gliomas based on the histology and molecular biomarkers by the 2016 World Health Organization (WHO) classification.
◼ ACE1702 is the first antibody-conjugated NK cell therapy in clinical development for the treatment of HER2-expressing solid tumors
◼ Clinical trial expected to enroll up to 24 patients across the U.S.